Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

SELL
$57.89 - $64.73 $152,771 - $170,822
-2,639 Reduced 42.93%
3,508 $203,000
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $11,595 - $12,874
182 Added 3.05%
6,147 $393,000
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $94,841 - $104,453
1,306 Added 28.03%
5,965 $459,000
Q4 2021

Jan 27, 2022

SELL
$53.63 - $62.52 $13,943 - $16,255
-260 Reduced 5.29%
4,659 $290,000
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $86,802 - $101,677
1,467 Added 42.5%
4,919 $291,000
Q1 2021

Apr 26, 2021

SELL
$59.34 - $66.74 $3,085 - $3,470
-52 Reduced 1.48%
3,452 $218,000
Q4 2020

Feb 02, 2021

BUY
$57.74 - $65.43 $3,002 - $3,402
52 Added 1.51%
3,504 $217,000
Q2 2020

Jul 21, 2020

BUY
$54.82 - $64.09 $189,238 - $221,238
3,452 New
3,452 $203,000
Q1 2020

Apr 29, 2020

SELL
$46.4 - $67.43 $163,652 - $237,825
-3,527 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $173,563 - $226,398
3,527 New
3,527 $226,000
Q2 2019

Jul 30, 2019

SELL
$44.62 - $49.34 $205,252 - $226,964
-4,600 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $451 - $538
10 Added 0.22%
4,600 $219,000
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $487 - $632
-10 Reduced 0.22%
4,590 $239,000
Q3 2018

Aug 21, 2019

SELL
$55.19 - $62.25 $4,194 - $4,731
-76 Reduced 1.63%
4,600 $286,000
Q2 2018

Aug 21, 2019

BUY
$50.53 - $62.98 $50 - $62
1 Added 0.02%
4,676 $259,000
Q3 2017

Aug 21, 2019

SELL
$55.23 - $63.74 $4,142 - $4,780
-75 Reduced 1.58%
4,675 $298,000
Q2 2017

Aug 21, 2019

SELL
N/A
-345 Reduced 6.77%
4,750 $264,000
Q1 2017

Aug 21, 2019

SELL
N/A
-90 Reduced 1.74%
5,095 $277,000
Q4 2016

Aug 21, 2019

SELL
N/A
-310 Reduced 5.64%
5,185 $303,000
Q3 2016

Aug 21, 2019

SELL
N/A
-36,147 Reduced 86.8%
5,495 $296,000
Q2 2016

Aug 21, 2019

BUY
N/A
297 Added 0.72%
41,642 $3.06 Million
Q1 2016

Aug 21, 2019

BUY
N/A
36,300 Added 719.52%
41,345 $2.64 Million
Q1 2015

Aug 21, 2019

BUY
N/A
222 Added 4.6%
5,045 $325,000
Q4 2014

Aug 21, 2019

BUY
N/A
228 Added 4.96%
4,823 $285,000
Q1 2014

Aug 22, 2019

SELL
N/A
-25 Reduced 0.54%
4,595 $239,000
Q4 2013

Aug 22, 2019

BUY
N/A
4,620
4,620 $246,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ascent Wealth Partners, LLC Portfolio

Follow Ascent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Wealth Partners, LLC with notifications on news.